Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Gurtner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
In Vivo (Athens, Greece)|February 27, 2026
Stereotactic Radiotherapy for Metastatic Anaplastic Thyroid Cancer: A Single-center Experience and Systematic ReviewRobert Rennollet, Ralph Gurtner, Claus Belka, et al.
In Vivo (Athens, Greece)|August 28, 2025
Complementary and Alternative Medicine (CAM) Use in Patients Undergoing Radiotherapy: Sex-specific Prevalence and Associations of Use Based on the S3 Guideline Complementary Medicine in Oncology QuestionnaireLukas Käsmann, Ralph Gurtner, Robert Rennollet, et al.
BMC Cancer|November 29, 2024
Validation of two predictive models for survival in anaplastic thyroid cancer (ATC)Lukas Käsmann, Alexander Nieto, Robert Rennollet, et al.
Journal of Cancer Research and Clinical Oncology|December 23, 2025
Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC)Teresa Augustin, Dmytro Oliinyk, Marlen Haderlein, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
In Vivo (Athens, Greece)|February 27, 2026
Stereotactic Radiotherapy for Metastatic Anaplastic Thyroid Cancer: A Single-center Experience and Systematic ReviewRobert Rennollet, Ralph Gurtner, Claus Belka, et al.
In Vivo (Athens, Greece)|August 28, 2025
Complementary and Alternative Medicine (CAM) Use in Patients Undergoing Radiotherapy: Sex-specific Prevalence and Associations of Use Based on the S3 Guideline Complementary Medicine in Oncology QuestionnaireLukas Käsmann, Ralph Gurtner, Robert Rennollet, et al.
BMC Cancer|November 29, 2024
Validation of two predictive models for survival in anaplastic thyroid cancer (ATC)Lukas Käsmann, Alexander Nieto, Robert Rennollet, et al.
Journal of Cancer Research and Clinical Oncology|December 23, 2025
Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC)Teresa Augustin, Dmytro Oliinyk, Marlen Haderlein, et al.
Pageof 1